ITUB20152779A1 - PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA - Google Patents
PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA Download PDFInfo
- Publication number
- ITUB20152779A1 ITUB20152779A1 ITUB2015A002779A ITUB20152779A ITUB20152779A1 IT UB20152779 A1 ITUB20152779 A1 IT UB20152779A1 IT UB2015A002779 A ITUB2015A002779 A IT UB2015A002779A IT UB20152779 A ITUB20152779 A IT UB20152779A IT UB20152779 A1 ITUB20152779 A1 IT UB20152779A1
- Authority
- IT
- Italy
- Prior art keywords
- proline
- protected
- keto
- oxidation
- boc
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 21
- 238000003786 synthesis reaction Methods 0.000 title description 10
- 230000015572 biosynthetic process Effects 0.000 title description 9
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 title description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 34
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- -1 N-protected 4-hydroxy-prolins Chemical class 0.000 claims description 23
- 230000003647 oxidation Effects 0.000 claims description 19
- 238000007254 oxidation reaction Methods 0.000 claims description 19
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 8
- 150000007530 organic bases Chemical class 0.000 claims description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- CKYGSXRXTIKGAJ-ZETCQYMHSA-N Boc-L-Pro(4-oxo) Chemical compound CC(C)(C)OC(=O)N1CC(=O)C[C@H]1C(O)=O CKYGSXRXTIKGAJ-ZETCQYMHSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- 238000007792 addition Methods 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 2
- BENKAPCDIOILGV-MLWJPKLSSA-N (2s)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical group CC(C)(C)OC(=O)N1CC(O)C[C@H]1C(O)=O BENKAPCDIOILGV-MLWJPKLSSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 18
- 239000007787 solid Substances 0.000 description 13
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 229940043279 diisopropylamine Drugs 0.000 description 6
- 230000001590 oxidative effect Effects 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- BENKAPCDIOILGV-RQJHMYQMSA-N (2s,4r)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(O)=O BENKAPCDIOILGV-RQJHMYQMSA-N 0.000 description 4
- 238000004537 pulping Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 231100000024 genotoxic Toxicity 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- IHUCSGIERDPZSG-DTIOYNMSSA-N (2S)-4-hydroxy-1-phenylmethoxypyrrolidine-2-carboxylic acid Chemical compound C(C1=CC=CC=C1)ON1[C@H](C(=O)O)CC(C1)O IHUCSGIERDPZSG-DTIOYNMSSA-N 0.000 description 1
- HFXAFXVXPMUQCQ-BYPYZUCNSA-N 4-oxo-L-proline Chemical compound OC(=O)[C@@H]1CC(=O)CN1 HFXAFXVXPMUQCQ-BYPYZUCNSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Tires In General (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Description
RIASSUNTO SUMMARY
“PROCESSO PER LA SINTESI DI 4-CHETO PROLINA PROTETTA” "PROCESS FOR THE SYNTHESIS OF PROTECTED 4-KETO PROLINA"
Si descrive un processo per la sintesi di 4-cheto proline-N-protette (1), a partire dalla corrispondente 4-idrossi-prolina protetta, in presenza del sistema ossidante PsOg/dimetilsolfossido (DMSO): A process for the synthesis of 4-keto proline-N-protected (1), starting from the corresponding protected 4-hydroxy-proline, in the presence of the oxidizing system PsOg / dimethyl sulfoxide (DMSO) is described:
\ \
PG PG
4-c lu· fa»- ji rwl ina jir ulLfta 4-c lu · fa »- ji rwl ina jir ulLfta
a» to"
Detto processo può essere applicato anche in presenza di un centro chirale in posizione portante l’acido carbossilico (posizione 3) senza epimerizzazione rilevante di quest’ultimo centro. This process can also be applied in the presence of a chiral center in the position carrying the carboxylic acid (position 3) without significant epimerization of the latter center.
Detto processo è particolarmente vantaggioso dal punto di vista ambientale, delle rese, della produttività e della purezza del prodotto ottenuto, in quanto non impiega l’utilizzo di ossidanti a base cromo, metalli quali rutenio o sistema ossidanti precursori di impurezze genotossiche. This process is particularly advantageous from an environmental point of view, yields, productivity and purity of the product obtained, as it does not employ the use of chromium-based oxidants, metals such as ruthenium or oxidizing system precursors of genotoxic impurities.
“PROCESSO PER LA SINTESI DI 4-CHETO PROLINA PROTETTA” "PROCESS FOR THE SYNTHESIS OF PROTECTED 4-KETO PROLINA"
L’invenzione riguarda n processo di preparazione di 4-cheto proline N-protette per ossidazione delle corrispondenti 4-idrossi-proline N-protette. The invention relates to the preparation process of N-protected 4-keto proline by oxidation of the corresponding N-protected 4-hydroxy-prolins.
SFONDO DELL’INVENZIONE BACKGROUND OF THE INVENTION
I derivati 4-cheto prolinici sono importanti intermedi per la preparazione, tra l’altro, di ACE inibitori, utilizzati per il trattamento di ipertensione e malattie cardiovascolari. The 4-keto prolin derivatives are important intermediates for the preparation, among other things, of ACE inhibitors, used for the treatment of hypertension and cardiovascular diseases.
Come riportato in letteratura (JACS 1957, 79, 185-92), i derivati 4-cheto prolinici sono instabili, specie in condizioni basiche, dove possono dare condensazione aldolica o apertura dell’anello con generazione di sottoprodotti e impurezze. As reported in the literature (JACS 1957, 79, 185-92), 4-keto prolin derivatives are unstable, especially in basic conditions, where they can give aldol condensation or ring opening with the generation of by-products and impurities.
La sintesi degli intermedi 4-cheto prolinici tramite ossidazione dai corrispondenti derivati ossidrilici è descritta in diversi brevetti e articoli. The synthesis of 4-keto proline intermediates by oxidation from the corresponding hydroxyl derivatives is described in several patents and articles.
DD283626A5 descrive l’ossidazione della N-benzilossi-4-idrossi prolina via complesso Piridina-SOs. Anche se l’ossidazione descritta è in assenza di metalli, lo svantaggio principale risiede nell’impiego della piridina, altamente tossica. DD283626A5 describes the oxidation of N-benzyloxy-4-hydroxy proline via the pyridine-SOs complex. Although the oxidation described is in the absence of metals, the main disadvantage lies in the use of highly toxic pyridine.
Sono riportati anche metodi tradizionali di ossidazione utilizzando il reattivo di Jones, a base di cromo. Come noto, questi sistemi ossidativi contenti cromo sono altamente tossici ( US4296113 , JOC2001, 66, 3593; J0C2 002, 67,71 62 ) , Traditional methods of oxidation using the Jones reagent, based on chromium, are also reported. As known, these chromium-containing oxidative systems are highly toxic (US4296113, JOC2001, 66, 3593; J0C2 002, 67,71 62),
In Organic Process Research & Development, 19(1), 270-283; 2015, si descrive l’ossidazione dell’idrossi prolina N-BOC utilizzando come sistema ossidante TEMPO/ipoclorito, il quale, come noto, può generare impurezze genotossiche. In Organic Process Research & Development, 19 (1), 270-283; 2015, the oxidation of hydroxy proline N-BOC is described using TEMPO / hypochlorite as an oxidizing system, which, as known, can generate genotoxic impurities.
US 8618310 descrive un’ossidazione in fase acquosa omogenea in presenza di Ru02e NaI04in accordo al seguente schema: US 8618310 describes a homogeneous aqueous phase oxidation in the presence of Ru02 and NaI04 in accordance with the following scheme:
RuO-i/NalO RuO-i / NalO
PG \ PG PG \ PG
Il prodotto che si forma precipita preservando in questo modo ulteriori reazioni di ossidazione e degradazione. Anche se dal punto di vista tossicologico e ambientale detta ossidazione risulta avere impatto minore rispetto alla letteratura precedentemente descritta, si ha tuttavia l’utilizzo di Rutenio che, oltre ad avere un certo impatto economico, necessita anche di uno stretto controllo nel prodotto isolato per limitarne la contaminazione da metalli pesanti. The resulting product precipitates, thus preserving further oxidation and degradation reactions. Even if from a toxicological and environmental point of view, said oxidation has a lower impact than the previously described literature, however, there is the use of Ruthenium which, in addition to having a certain economic impact, also requires strict control in the isolated product to limit it. heavy metal contamination.
DESCRIZIONE DELL’INVENZIONE DESCRIPTION OF THE INVENTION
Si è ora trovato un vantaggioso processo di ossidazione dei derivati 4-idrossi prolinici in cui l’ossidazione è ottenuta utilizzando il sistema ossidante P2Q5/DMSO in condizioni basiche, con successivo isolamento in condizioni controllate al fine di prevenirne la degradazione nota in letteratura. An advantageous oxidation process of 4-hydroxy proline derivatives has now been found in which oxidation is obtained using the oxidizing system P2Q5 / DMSO in basic conditions, with subsequent isolation under controlled conditions in order to prevent degradation known in the literature.
Il processo dell’invenzione è riportato nello schema seguente: The process of the invention is shown in the following diagram:
PG PG
in cui PG è un gruppo protettivo del gruppo amminico (come descritto nel libro: “Protective Groups in Organic Synthesis, Third Edition. T.W. Greene”) che comprende una funzione carbonilica ed è legato attraverso questa funzione all’azoto amminico. Uno dei gruppi più comuni è il ter-butilossicarbonile (BOC). in which PG is a protective group of the amino group (as described in the book: "Protective Groups in Organic Synthesis, Third Edition. T.W. Greene") which includes a carbonyl function and is linked through this function to the amino nitrogen. One of the most common groups is tert-butyloxycarbonyl (BOC).
Il processo è costituito da un solo stadio di ossidazione al quale segue l’isolamento del prodotto. Il prodotto può essere purificato come sale di basi organiche o inorganiche e poi isolato nuovamente come acido carbossilico. The process consists of a single oxidation stage which is followed by the isolation of the product. The product can be purified as an organic or inorganic base salt and then isolated again as carboxylic acid.
L’ossidazione avviene in una miscela di solventi organici, ad esempio una miscela di diclorometano e dimetilsolfossido oppure in dimetilsolfossido puro. Oxidation occurs in a mixture of organic solvents, for example a mixture of dichloromethane and dimethyl sulfoxide or in pure dimethyl sulfoxide.
L’ossidazione avviene per aggiunte consecutive di anidride solforica (P2O5) e di una base organica come per esempio diisopropiletilammina o trietilammina. Oxidation occurs by consecutive additions of sulfuric anhydride (P2O5) and an organic base such as diisopropylethylamine or triethylamine.
A conversione ultimata, la miscela di reazione è spenta ed estratta in solvente organico. Upon completion of the conversion, the reaction mixture is quenched and extracted in organic solvent.
Il prodotto di reazione è quindi precipitato dalla soluzione organica concentrata di fine workup in forma salificata, per esempio come sale di feniletilammina, naftilammina o dicicloesilammina. The reaction product is then precipitated from the fine workup concentrated organic solution in salified form, for example as a phenylethylamine, naphthylamine or dicyclohexylamine salt.
La successiva desalificazione in solvente organico quale metiltertbutiletere e successiva precipitazione da acetonitrile fornisce il prodotto di ossidazione desiderato in elevata purezza. The subsequent desalting in an organic solvent such as methyltertbutyl ether and subsequent precipitation by acetonitrile provides the desired oxidation product in high purity.
Secondo una versione preferita dell’invenzione, il processo è eseguito come segue: According to a preferred version of the invention, the process is performed as follows:
1 mole di idrossi prolina N-protetta viene basificata con 1.0-1.1 moli di base organica, preferibilmente diisopropilammina in dimetilsolfossido. Si impiegano 5-25 volumi di solvente, preferibilmente 14÷ 16 volumi rispetto alla quantità di idrossi prolina N-protetta, o miscele di dimetilsolfossido/cloruro di metilene. Ad una temperatura inferiore a 25°C, preferibilmente alla temperatura compresa tra 15°C-18°C si aggiunge, a porzioni, la base organica, preferibilmente diisopropilammina, in aliquote di 0.25-0.65 moli alla volta, preferibilmente 0.4-0. 5 moli, per un totale di 7÷18 porzioni, preferibilmente 9÷11 porzioni, e, in rapida successione, porzioni di anidride fosforica, in aliquote di 0.08-0.21 moli alla volta, preferibilmente 0.14-0.17 moli, per un totale di 7÷18 porzioni, preferibilmente 9÷ 11 porzioni ad una temperatura al di sotto di 25°C, preferibilmente alla temperatura compresa tra 15°C-20°C. 1 mole of N-protected hydroxy proline is basified with 1.0-1.1 mole of organic base, preferably diisopropylamine in dimethyl sulfoxide. 5-25 volumes of solvent are used, preferably 14 ÷ 16 volumes with respect to the quantity of N-protected hydroxy proline, or mixtures of dimethylsulfoxide / methylene chloride. At a temperature lower than 25 ° C, preferably at a temperature between 15 ° C-18 ° C, the organic base, preferably diisopropylamine, is added in portions in aliquots of 0.25-0.65 moles at a time, preferably 0.4-0. 5 moles, for a total of 7 ÷ 18 portions, preferably 9 ÷ 11 portions, and, in rapid succession, portions of phosphoric anhydride, in aliquots of 0.08-0.21 moles at a time, preferably 0.14-0.17 moles, for a total of 7 ÷ 18 portions, preferably 9 ÷ 11 portions at a temperature below 25 ° C, preferably at a temperature between 15 ° C-20 ° C.
La reazione è controllata mediante analisi UPLC utilizzando una colonna ACQUITY BEH C18 e acqua/acetonitrile/ 0,1% di trifluoroacetico come fase eluente. The reaction is controlled by UPLC analysis using an ACQUITY BEH C18 column and water / acetonitrile / 0.1% trifluoroacetic as the eluent phase.
A reazione terminata si acidifica a PH compreso tra 2.0-4.0, preferibilmente 2. 5-3. 5 con acido cloridrico. At the end of the reaction it is acidified to a pH of between 2.0-4.0, preferably 2. 5-3. 5 with hydrochloric acid.
Si estrae quindi con un solvente organico, preferibilmente cloruro di metilene contro-estraendo la fase acquosa per recuperare prodotto con il medesimo solvente. Dopo concentrazione si ottiene un olio utilizzabile direttamente nel successivo stadio di salificazione. It is then extracted with an organic solvent, preferably methylene chloride by counter-extracting the aqueous phase to recover product with the same solvent. After concentration, an oil is obtained which can be used directly in the subsequent salification stage.
L’olio ottenuto è disciolto in solvente organico, preferibilmente etilacetato. Si impiegano 5-8 volumi di solvente, preferibilmente 6÷7 volumi rispetto alla quantità di Idrossi prolina N-protetta iniziale. Alla soluzione ottenuta, ad una temperatura al di sotto di 25 °C, preferibilmente compresa tra 20°C-25°C, si aggiunge 1.5-2. 5 moli di base organica, feniletilammina o naftilammina o dicicloesilammina. Tali moli sono riferite al contenuto di idrossi prolina N-protetta presente nell’olio di partenza titolata. The oil obtained is dissolved in organic solvent, preferably ethyl acetate. 5-8 volumes of solvent are used, preferably 6 ÷ 7 volumes with respect to the initial quantity of N-protected hydroxy proline. To the solution obtained, at a temperature below 25 ° C, preferably between 20 ° C-25 ° C, 1.5-2 is added. 5 moles of organic base, phenylethylamine or naphthylamine or dicyclohexylamine. These moles refer to the N-protected proline hydroxy content present in the titrated starting oil.
La sospensione così ottenuta viene filtrata. Il solido così ottenuto, se necessario, può essere ulteriormente purificato mediante ricristallizzazione o spappolamento da etilacetato o da altri solventi noti. The suspension thus obtained is filtered. The solid thus obtained, if necessary, can be further purified by recrystallization or pulping from ethyl acetate or other known solvents.
Il sale dell’acido della 4-cheto prolina N-protetta è quindi sciolto in 3-5 volumi di acqua e 4-6 volumi di solvente organico, preferibilmente metiltertbutiletere. La sospensione ottenuta è acidificata con acidi inorganici, preferibilmente acido fosforico, e la fase organica evaporata a secchezza. L’olio ottenuto è quindi disciolto in 3-5 volumi rispetto al sale di partenza in solvente organico, preferibilmente etilacetato. The acid salt of the N-protected 4-keto proline is then dissolved in 3-5 volumes of water and 4-6 volumes of organic solvent, preferably methyltertbutyl ether. The suspension obtained is acidified with inorganic acids, preferably phosphoric acid, and the organic phase evaporated to dryness. The oil obtained is then dissolved in 3-5 volumes with respect to the starting salt in organic solvent, preferably ethyl acetate.
Il solido filtrato viene essiccato sotto vuoto alla temperatura di 45°C-55°C per ottenere 4-cheto prolina N-protetta. The filtered solid is dried under vacuum at a temperature of 45 ° C-55 ° C to obtain N-protected 4-keto proline.
Il solido così ottenuto, se necessario, può essere ulteriormente purificato mediante ricristallizzazione o spappolamento da etilacetato o da altri solventi organici noti in letteratura. The solid thus obtained, if necessary, can be further purified by recrystallization or pulping from ethyl acetate or other organic solvents known in the literature.
Il processo dell’invenzione è particolarmente vantaggioso in quanto, a differenza dei processi noti, è condotto senza l’utilizzo di sistemi ossidanti contenenti specie dannose o tossiche, ed in assenza di metalli il cui utilizzo andrebbe strettamente monitorato nel prodotto isolato. Anche dal punto di vista economico detta ossidazione presenta il vantaggio di utilizzare reagenti a basso impatto di costo e i cui sottoprodotti sono facilmente rimovibili in fase acquosa. The process of the invention is particularly advantageous since, unlike known processes, it is conducted without the use of oxidizing systems containing harmful or toxic species, and in the absence of metals whose use should be strictly monitored in the isolated product. Also from the economic point of view, said oxidation has the advantage of using reagents with a low cost impact and whose by-products are easily removable in the aqueous phase.
Infine detto processo risulta essere sicuro anche dal punto di vista calorimetrico ed è pertanto scalabile in impianto industriale. Finally, said process is also safe from the calorimetric point of view and is therefore scalable in an industrial plant.
L’invenzione è illustrata in dettaglio nei seguenti esempi. The invention is illustrated in detail in the following examples.
Esempio 1: sintesi di N-BOC-4-cheto prolina sale di naftilammina Ad una soluzione di N-BOC idrossi prolina (25 g, 0,108 moli) in dimetilsolfossido (350 mi) si aggiunge diisopropilammina (14,0 g, 0,108 moli). Si raffredda quindi la soluzione ottenuta a 16-1 7°C e si aggiunge in 10 porzioni circa aliquote di diisopropilammina (6,28 g, 0,0486 moli) seguite da corrispondenti aliquote di anidride fosforica (4,60g, 0,0162 moli). Example 1: synthesis of N-BOC-4-keto proline naphthylamine salt To a solution of N-BOC hydroxy proline (25 g, 0.108 moles) in dimethyl sulfoxide (350 ml) diisopropylamine (14.0 g, 0.108 moles) is added . The solution obtained is then cooled to 16-1 7 ° C and approximately 10 portions of diisopropylamine aliquots (6.28 g, 0.0486 moles) are added followed by corresponding aliquots of phosphoric anhydride (4.60g, 0.0162 moles). ).
Si controlla quindi la reazione tramite UPLC. A reazione terminata si gocciola lentamente la miscela di reazione in una miscela di cloruro di metilene (250 mi) e acqua (30 mi) a pH 3.0±0.5, a una temperatura compresa tra 0-5°C e mantenendo il pH costante compreso tra 3.0±0.5 mediante aggiunta simultanea di acido cloridrico (circa 40 mi). The reaction is then controlled by UPLC. At the end of the reaction, the reaction mixture is slowly dropped into a mixture of methylene chloride (250 ml) and water (30 ml) at pH 3.0 ± 0.5, at a temperature between 0-5 ° C and keeping the pH constant between 3.0 ± 0.5 by simultaneous addition of hydrochloric acid (about 40 ml).
Dopo aver separato le fasi la fase acquosa è contro estratta con diclorometano (150 mi) e le fasi organiche riunite lavate con acqua (2X100 mi). After separating the phases, the aqueous phase is counter-extracted with dichloromethane (150 ml) and the combined organic phases washed with water (2X100 ml).
Si concentra quindi a olio anidrificando con etilacetato. It is then concentrated in oil by drying with ethyl acetate.
L’olio ottenuto è disciolto in etilacetato (162 mi). Alla soluzione ottenuta, ad una temperatura compresa tra 20°C-25°C, si aggiunge naftilammina (18,6 g, 0,13 moli). Il prodotto ottenuto è filtrato e lavato con etilacetato (41 mi). The oil obtained is dissolved in ethyl acetate (162 ml). To the solution obtained, at a temperature between 20 ° C-25 ° C, naphthylamine (18.6 g, 0.13 moles) is added. The obtained product is filtered and washed with ethyl acetate (41 ml).
Il solido isolato viene essiccato a pressione ridotta a 50°C ottenendo N-BOC-4-cheto prolina sale di naftilammina (24,2 g, 0,065 mol) come solido bianco. Resa molare da N-BOC-idrossi prolina: 60%. The isolated solid is dried under reduced pressure at 50 ° C to obtain N-BOC-4-keto proline naphthylamine salt (24.2 g, 0.065 mol) as a white solid. Molar yield from N-BOC-hydroxy proline: 60%.
Esempio 2: sintesi di N-BOC-4-cheto prolina da N-BOC-4-cheto prolina sale di naftilammina Example 2: synthesis of N-BOC-4-keto proline from N-BOC-4-keto proline naphthylamine salt
Si sospendono 23,2 g di sale di naftilammina della 4-cheto prolina N-protetta (93%, 0,058 mol) in una miscela di 100 mi di acqua e 250 mi di metiltertbutiletere. Alla sospensione si aggiunge acido fosforico 85% fino a pH 2±0.5. Si separano le fasi e la fase acquosa si contro- e strae con metiltertbutil etere (125 mi). Le fasi organiche riunite si lavano quindi con acqua (50 mi) e si evapora a secchezza, anidrificando con etilacetato (3X50 mi). Al residuo oleoso ottenuto si aggiunge etilacetato (25 mi) e si agita a 25±5°C per IH. Si filtra quindi il solido lavando con etilacetato (10 mi). Il prodotto ottenuto è quindi essiccato a pressione ridotta alla temperatura di 50°C per ottenere 4-cheto prolina N-protetta (12,2 g, 0,053 mol) come solido bianco. Purezza HPLC: 99,5% 23.2 g of N-protected 4-keto proline naphthylamine salt (93%, 0.058 mol) are suspended in a mixture of 100 ml of water and 250 ml of methyl tertbutyl ether. 85% phosphoric acid is added to the suspension up to pH 2 ± 0.5. The phases are separated and the aqueous phase is countered with methyl tert-butyl ether (125 ml). The combined organic phases are then washed with water (50 ml) and evaporated to dryness, anhydrifying with ethyl acetate (3X50 ml). Ethyl acetate (25 ml) is added to the oily residue obtained and stirred at 25 ± 5 ° C for 1H. The solid is then filtered by washing with ethyl acetate (10 ml). The product obtained is then dried under reduced pressure at a temperature of 50 ° C to obtain N-protected 4-keto proline (12.2 g, 0.053 mol) as a white solid. HPLC purity: 99.5%
Resa molare da N-BOC-cheto prolina sale di naftilammina: 91%. Molar yield from N-BOC-keto proline naphthylamine salt: 91%.
Il solido così ottenuto, se necessario, può essere ulteriormente purificato mediante ricristallizzazione o spappolamento da etilacetato o da altri solventi organici noti. The solid thus obtained, if necessary, can be further purified by recrystallization or pulping from ethyl acetate or other known organic solvents.
UPLC-MS [M+H+] = 228 UPLC-MS [M + H +] = 228
IH NMR (400 MHz, DMSO) 1H NMR (400 MHz, DMSO)
δ 12.85 (s, IH), 4.54 (m, IH), 3.86-3.78 (m, IH), 3.69-3.64 (m, IH), 3.16-3.06 (m, IH), 2.53-2.45 (m, IH DMSO), 1.42 and 1.40 (2 x s, 9H). δ 12.85 (s, IH), 4.54 (m, IH), 3.86-3.78 (m, IH), 3.69-3.64 (m, IH), 3.16-3.06 (m, IH), 2.53-2.45 (m, IH DMSO ), 1.42 and 1.40 (2 x s, 9H).
Esempio 3: sintesi di N-BOC-4-cheto prolina sale di dicicloesilammina Example 3: synthesis of N-BOC-4-keto proline dicyclohexylamine salt
Ad una soluzione di N-BOC idrossi prolina (37,5 g, 0,162 moli) in dimetilsolfossido (530 mi) si aggiunge diisopropilammina (21,0 g, 0,162 moli). Si raffredda quindi la soluzione ottenuta a 16-17°C e si aggiunge in 10 porzioni circa aliquote di diisopropilammina (9,42 g, 0,0729 moli) seguite da corrispondenti aliquote di anidride fosforica (6,90 g, 0,0243 moli). Diisopropylamine (21.0 g, 0.162 mol) is added to a solution of N-BOC hydroxy proline (37.5 g, 0.162 mol) in dimethyl sulfoxide (530 ml). The solution obtained is then cooled to 16-17 ° C and approximately 10 portions of diisopropylamine aliquots (9.42 g, 0.0729 moles) are added followed by corresponding aliquots of phosphoric anhydride (6.90 g, 0.0243 moles). ).
Si controlla quindi la reazione tramite UPLC. A reazione terminata si gocciola lentamente la miscela di reazione in una miscela di cloruro di metilene (400 mi) e acqua (45 mi) a pH 3.0±0.5, a una temperatura compresa tra 0-5°C e mantenendo il pH costante compreso tra 3.0±0.5 mediante aggiunta simultanea di acido cloridrico (circa 60 mi). The reaction is then controlled by UPLC. At the end of the reaction, the reaction mixture is slowly dropped into a mixture of methylene chloride (400 ml) and water (45 ml) at pH 3.0 ± 0.5, at a temperature between 0-5 ° C and keeping the pH constant between 3.0 ± 0.5 by simultaneous addition of hydrochloric acid (about 60 ml).
Dopo aver separato le fasi la fase acquosa è contro estratta con diclorometano (230 mi) e le fasi organiche riunite lavate con acqua (2X150 mi). After separating the phases, the aqueous phase is counter-extracted with dichloromethane (230 ml) and the combined organic phases washed with water (2X150 ml).
Si concentra quindi a olio anidrificando con etilacetato. It is then concentrated in oil by drying with ethyl acetate.
L’olio ottenuto è disciolto in etilacetato (250 mi). Alla soluzione ottenuta, ad una temperatura compresa tra 20°C-25°C, si aggiunge dicloesilammina (35,3 g, 0,2 moli). Il prodotto ottenuto è filtrato e lavato con etilacetato (60 mi). The oil obtained is dissolved in ethyl acetate (250 ml). To the solution obtained, diclohexylamine (35.3 g, 0.2 moles) is added at a temperature between 20 ° C-25 ° C. The obtained product is filtered and washed with ethyl acetate (60 ml).
Il solido isolato viene essiccato a pressione ridotta a 50°C ottenendo N-BOC-4-cheto prolina sale di dicicloesilammina (45,2 g, 0,11 mol) come solido bianco. The isolated solid is dried under reduced pressure at 50 ° C to obtain N-BOC-4-keto proline salt of dicyclohexylamine (45.2 g, 0.11 mol) as a white solid.
Resa molare da N-BOC-idrossi prolina: 68%. Molar yield from N-BOC-hydroxy proline: 68%.
Esempio 4: sintesi di N-BOC-4-cheto prolina da N-BOC-4-cheto prolina sale di dicicloesilammina Example 4: synthesis of N-BOC-4-keto proline from N-BOC-4-keto proline dicyclohexylamine salt
Si sospendono 40 g di sale di dicicloesilammina della 4-cheto prolina N-protetta (93%, 0,09 mol) in una miscela di 155 mi di acqua e 390 mi di metiltertbutiletere. Alla sospensione si aggiunge acido fosforico 85% fino a pH 2±0.5. Si separano le fasi e la fase acquosa si contro-estrae con metiltertbutil etere (200 mi). Le fasi organiche riunite si lavano quindi con acqua (80 mi) e si evapora a secchezza, anidrificando con etilacetato (3X80 mi). Al residuo oleoso ottenuto si aggiunge etilacetato (31 mi) e si agita a 25±5°C per IH. Si filtra quindi il solido lavando con etilacetato (15 mi). Il prodotto ottenuto è quindi essiccato a pressione ridotta alla temperatura di 50°C per ottenere 4-cheto prolina N-protetta (19 g, 0,083 mol) come solido bianco. Purezza HPLC: 99,6%. 40 g of N-protected 4-keto proline dicyclohexylamine salt (93%, 0.09 mol) are suspended in a mixture of 155 ml of water and 390 ml of methyl tertbutyl ether. 85% phosphoric acid is added to the suspension up to pH 2 ± 0.5. The phases are separated and the aqueous phase is counter-extracted with methyl tert-butyl ether (200 ml). The combined organic phases are then washed with water (80 ml) and evaporated to dryness, anhydrifying with ethyl acetate (3X80 ml). Ethyl acetate (31 ml) is added to the oily residue obtained and stirred at 25 ± 5 ° C for 1H. The solid is then filtered by washing with ethyl acetate (15 ml). The product obtained is then dried under reduced pressure at a temperature of 50 ° C to obtain N-protected 4-keto proline (19 g, 0.083 mol) as a white solid. HPLC purity: 99.6%.
Resa molare da N-BOC-cheto prolina sale di dicicloesilammina: 92%. Il solido così ottenuto, se necessario, può essere ulteriormente purificato mediante ricristallizzazione o spappolamento da etilacetato o da altri solventi organici noti. Molar yield from N-BOC-keto proline dicyclohexylamine salt: 92%. The solid thus obtained, if necessary, can be further purified by recrystallization or pulping from ethyl acetate or other known organic solvents.
UPLC-MS [M+H+] = 228 UPLC-MS [M + H +] = 228
IH NMR (400 MHz, DMSO) 1H NMR (400 MHz, DMSO)
δ 12.85 (s, IH), 4.54 (m, IH), 3.86-3.78 (m, IH), 3.69-3.64 (m, IH), 3.16-3.06 (m, IH), 2.53-2.45 (m, IH DMSO), 1.42 and 1.40 (2 x s, 9H). δ 12.85 (s, IH), 4.54 (m, IH), 3.86-3.78 (m, IH), 3.69-3.64 (m, IH), 3.16-3.06 (m, IH), 2.53-2.45 (m, IH DMSO ), 1.42 and 1.40 (2 x s, 9H).
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A002779A ITUB20152779A1 (en) | 2015-08-03 | 2015-08-03 | PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA |
PCT/EP2016/068347 WO2017021378A1 (en) | 2015-08-03 | 2016-08-01 | Process for the synthesis of protected 4-keto-proline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A002779A ITUB20152779A1 (en) | 2015-08-03 | 2015-08-03 | PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUB20152779A1 true ITUB20152779A1 (en) | 2017-02-03 |
Family
ID=54601907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUB2015A002779A ITUB20152779A1 (en) | 2015-08-03 | 2015-08-03 | PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITUB20152779A1 (en) |
WO (1) | WO2017021378A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0752419A2 (en) * | 1995-07-04 | 1997-01-08 | Degussa Aktiengesellschaft | Process for the preparation of N-substituted 4-ketoproline derivatives |
WO2005095340A1 (en) * | 2004-03-03 | 2005-10-13 | Degussa Ag | Process for preparing n-protected 4-ketoproline derivatives |
CN102453033A (en) * | 2010-10-29 | 2012-05-16 | 上海医药工业研究院 | Method for producing hydantoin derivative |
-
2015
- 2015-08-03 IT ITUB2015A002779A patent/ITUB20152779A1/en unknown
-
2016
- 2016-08-01 WO PCT/EP2016/068347 patent/WO2017021378A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0752419A2 (en) * | 1995-07-04 | 1997-01-08 | Degussa Aktiengesellschaft | Process for the preparation of N-substituted 4-ketoproline derivatives |
WO2005095340A1 (en) * | 2004-03-03 | 2005-10-13 | Degussa Ag | Process for preparing n-protected 4-ketoproline derivatives |
CN102453033A (en) * | 2010-10-29 | 2012-05-16 | 上海医药工业研究院 | Method for producing hydantoin derivative |
Non-Patent Citations (2)
Title |
---|
CLAUDIO PALOMO ET AL: "New Synthesis of a-Amino Acid N-Carboxy Anhydrides through Baeyer-Villiger Oxidation of a-Keto &Lactamst", J. ORG. CHEM. BER. DTSCH. CHEM. GES.. DTSCH. CHEM. GES. J. P.; WINITZ, M. CHEMISTRY OF THE AMINO ACIDS, 15 April 1994 (1994-04-15), pages 39 - 861, XP055236138, Retrieved from the Internet <URL:http://pubs.acs.org/doi/abs/10.1021/jo00090a033?journalCode=joceah&quickLinkVolume=59&quickLinkPage=3123&selectedTab=citation&volume=59> * |
TIDWELL T T: "OXIDATION OF ALCOHOLS BY ACTIVATED DIMETHYL SULFOXIDE AND RELATED REACTIONS: AN UPDATE", SYNTHESIS, GEORG THIEME VERLAG, STUTTGART, DE, no. 10, 1 October 1990 (1990-10-01), pages 857 - 870, XP000160078, ISSN: 0039-7881, DOI: 10.1055/S-1990-27036 * |
Also Published As
Publication number | Publication date |
---|---|
WO2017021378A1 (en) | 2017-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2801911C2 (en) | ||
Boivin et al. | Iminyl, amidyl, and carbamyl radicals from O-benzoyl oximes and O-benzoyl hydroxamic acid derivatives | |
SU747422A3 (en) | Method of producing proline derivatives | |
SE454273B (en) | CYCLIC HYDROXIIMIDES FOR USE IN THE PRODUCTION OF CYCLIC AMINO ACIDS AND PROCEDURES FOR THEIR PREPARATION | |
Baxendale et al. | The synthesis of neurotensin antagonist SR 48692 for prostate cancer research | |
KR20170020808A (en) | Method for producing synthetic pentapeptide | |
ITUB20152779A1 (en) | PROCESS FOR THE SYNTHESIS OF 4-PROTECTED CHETO PROLINA | |
Arnó et al. | Synthesis and cytotoxic activity of novel C7-functionalized spongiane diterpenes | |
Montgomery et al. | Convenient method for the synthesis of 2-fluoro-adenosine | |
CN105980385B (en) | The method for preparing oxo 6 (sulphur epoxide) mono-sodium salt of 2 nitrile of (2S, 5R) 1,6 diazabicylo [3.2.1] octane 7 | |
Pérez-Faginas et al. | Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors | |
Allan et al. | Synthesis of analogues of GABA. III. All four stereoisomers of 3-aminocyclopentanecarboxylic acid and a stereochemical correlation with amidinomycin | |
Sheehan et al. | Derivatives of 6. beta.-methylpenicillanic acid | |
DE69030590T2 (en) | N-protected (S) isoserine compounds | |
Cativiela et al. | Action of diazomethane on methyl (Z (or E))-2-(acylamino) cinnamates. A new route to methyl (Z)-2-(acylamino)-3-methylcinnamates | |
Vezenkov et al. | New Derivatives of Galantamine Containing Peptide Fragment | |
Matsuyama et al. | Conjugate addition of 6-membered hydrazine to chiral tert-butyl (E)-2-(p-tolylsulfinyl) cinnamates. Synthesis of (S)-celacinnine | |
Andreu et al. | Effect of addition of Lewis/Brönsted acids in the asymmetric aldol condensation catalyzed by trifluoroacetate salts of proline-based dipeptides | |
Shaitanova et al. | Synthesis of enantiomerically pure 4-polyfluoromethyl-4-hydroxy-homoprolines by intramolecular cyclization of 6-amino-5-polyfluoromethyl-hex-2-enoic acids | |
IT201800006337A1 (en) | LIFITEGRAST PREPARATION PROCEDURE | |
Wilt | The halodecarboxylation of cyanoacetic acid | |
SE462751B (en) | SET FOR MANUFACTURE OF A BRAND CAPACYL PROLINE | |
JPS595595B2 (en) | Method for producing 15-hydroxyimino-E-homoebrunane derivative | |
Hewkin et al. | New Synthesis of Substituted 2‐Carboxyindole Derivatives: Versatile Introduction of a Carbamoylethynyl Moiety at the C‐3 Position | |
US5326908A (en) | Process for the preparation of asparagine |